Home Clinical Topics FDA approves new drug for psoriasis

FDA approves new drug for psoriasis

On Feb. 15, the U.S. Food and Drug Administration (FDA) approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here